Effects of risperidone in autistic children and young adults: A Systematic Review and Meta-Analysis.

Conclusion, it was possible to suggest the efficacy of risperidone for the treatment of lethargy and inadequate speech. Finally, we emphasize that the risk-benefit in its use should be evaluated. Protocol number CRD42019122316.
PMID: 32469700 [PubMed - as supplied by publisher]

Source: Current Neuropharmacology - May 28, 2020 Category: Drugs & Pharmacology Authors: Mano-Sousa BJ, Pedrosa AM, Alves BC, Galduróz JCF, Belo VS, Chaves VE, Duarte-Almeida JM Tags: Curr Neuropharmacol Source Type: research